OBJECTIVES: It is unclear whether postoperative infections can be prevented by treating asymptomatic bacteriuria, or whether, on the other hand, such treatment will increase the risk of more serious infection by pathogenic bacteria different from the ones causing bacteriuria. This study aimed to support future treatment decisions for preoperative cardiothoracic surgery patients with asymptomatic bacteriuria, by examining current preoperative practice, in relation to postoperative outcome.
INTRODUCTION
The prevention of postoperative infections has always been an important clinical goal in cardiac surgery. Guidelines about preoperative infection prevention state that infections (outside the immediate surgical area) should be treated prior to operation if possible [1, 2] . It is not clear whether this is also true for asymptomatic bacteriuria [3] [4] [5] . Despite this uncertainty, it is institutional policy in at least 9 out of 16 Dutch cardiac surgery centres to actively search for bacteriuria the day prior to cardiothoracic surgery, for example, by testing urine for nitrite and/or leucocytes in all preoperative cardiothoracic patients.
Asymptomatic bacteriuria is usually defined as presence of bacteria in a urine sample (more than or equal to 10 5 colony-forming units per millilitre of the same organism) without clinical signs or symptoms of urinary tract infection [3] . Prevalence of asymptomatic bacteriuria in elderly, non-institutionalized patients is between 4 and 10% [6] . Pooled post-test probability of asymptomatic bacteriuria in surgical patients with nitrituria is 70%; if one or both nitrite or leucocytes are positive, the probability is 27% [7] . A urine sample negative for both nitrite and leucocytes rules out a urinary tract infection [7] .
When preoperatively asymptomatic bacteriuria is suspected, the discussion remains whether this bacteriuria should be treated.
According to the literature, treatment of asymptomatic bacteriuria has been proved to be beneficial only for selected patient groups (during pregnancy and before urological procedures) [8] .
Two opposing hypotheses regarding preoperative treatment of asymptomatic bacteriuria are described. The first hypothesis as described by Soltanzadeh et al. emphasizes the likelihood of an increased risk of bacteraemia, due to use of an indwelling urinary catheter in patients with bacteriuria, and the simultaneous use of extracorporeal circulation (ECC), which is likely to weaken the immune system. The haematogenous spread of bacteria may increase the risk of urosepsis, mediastinitis and, if prosthetic heart valves are used, endocarditis [9] [10] [11] [12] [13] . This hypothesis supports treatment of asymptomatic bacteriuria. The second hypothesis, described by Darouiche et al., states that treatment of asymptomatic colonization with bacteria of the urinary tract can lead to infections with more pathogenic bacteria [14] [15] [16] . In a recent study of Drekonja et al. [17] , treatment of preoperative patients (for orthopaedic, cardiothoracic and vascular procedures) with asymptomatic bacteriuria was associated with a higher number of surgical site infections. Therefore, treatment of asymptomatic bacteriuria would seem not advisable.
It is not surprising that these opposing theories lead to uncertainty and practice variation in treatment of asymptomatic bacteriuria in the preoperative period, and possibly to differences in postoperative outcome.
The aim of this study is to collect evidence to support future treatment decisions for preoperative asymptomatic bacteriuria in cardiothoracic surgery patients, by examining current preoperative practice, including refraining from antibiotics, in relation to incidence of postoperative infections and length of postoperative hospital stay.
METHODS
We conducted a retrospective cohort study based on digitally accessible data of all patients who underwent cardiothoracic surgery between 1 January 2011 and 31 December 2013 in St. Antonius Hospital in Netherlands.
A total of 5946 cardiovascular procedures were performed in this period (Fig. 1) . We did not perform any power calculations because our study was retrospective and because, in view of the high prevalence of asymptomatic bacteriuria according to the literature, we expected to have enough patients in the antibiotically treated group to be able to test our hypothesis. To identify patients with asymptomatic bacteriuria, urine is routinely screened for nitrite and leucocytes the day before surgery. If bacteriuria is suspected, antibiotic therapy is considered in consultation with a microbiologist. The culture results (which are not known until the postoperative period), including antibiogram, could be used for postoperative fine-tuning of antibiotics.
Routine preoperative laboratory tests include (among others) C-reactive protein levels (CRP) and creatinine. If the CRP level is higher than 10, extra attention is paid to diagnosing and treating possible infections, and sometimes surgery is even postponed.
The following precautions are standard practice in our preoperative cardiothoracic ward. Symptomatic infections before surgery are treated (including extra consultation with the otorhinolaryngologist, pulmonologist or dental specialist, if required), especially when prosthetic material is involved. If preoperative hair removal is necessary, this is done by clipping instead of shaving. All patients start with mupirocin nasal ointment 1-3 days prior to sternotomy. Hygiene regulations are according to guidelines of the Dutch Working Group of Infection Prevention [1] . In the operating room, before starting the procedure, an indwelling urinary catheter is placed following an aseptical protocol. All patients receive intravenous cefazolin 2000 mg. If surgery takes longer than 4 h, this is repeated with 1000 mg cefazolin. If prosthetic material (e.g. a heart valve) is involved, this is repeated 5 times in the first 40 postoperative hours. Postoperatively, at the intensive care unit, urine is routinely screened to detect multiresistant pathogens.
Data collection
All data were collected prospectively. A copy of the cardiothoracic surgery database which is used for evaluation purposes, served as the basis. This database contains information about the procedure, medical history of the patient, pre-, intra-and postoperative data. The EuroSCORE (EuroSCORE: Predicted operative mortality for patients undergoing cardiac surgery [18] ) is calculated per patient. We chose to only include patients with leucocyturia and/ or nitrituria, suggestive of asymptomatic bacteriuria. In order to detect these patients, we merged a copy of the cardiothoracic database with available preoperative urine test results, and with CRP test results, plasma creatinine levels and hospital admission data (to calculate postoperative length of stay) extracted from electronic health records. To answer our research questions, and in order to test the first hypothesis described in the introduction, only cardiothoracic surgery patients who were operated using ECC, and with nitrituria and/or leucocyturia, were selected from the resulting database. Since we were interested in routine procedures, we excluded patients undergoing emergency surgery or with symptomatic infections, as well as patients with active endocarditis, patients in a critical preoperative state and patients with a preoperative CRP level of more than >10 mg/l, or using antibiotics for reasons different from a urinary tract infection. The set of patients remaining after these exclusions was divided into two groups based on data about antibiotic prescriptions from the Clinical Pharmacy prescription database. The first group contained patients treated with antibiotics for urinary tract infections prior to surgery (AB+), the second group contained patients who did not receive any treatment (AB−), despite nitrite and/or leucocytes in their urine samples. For these 1002 patients our perfusionists provided height and weight, and body mass index (BMI) was calculated.
This resulting database was checked for duplicates, missing data and discrepancies. If postoperative antibiotic prescriptions were registered, but no infectious complication was registered, then infectious complications stated in the discharge letter were decisive.
To study over-treatment and haematogenous spread of bacteria, culture results of patients who received preoperative antibiotics, and culture results of patients with postoperative infections, were extracted from electronic health records.
Statistical analysis
Patient characteristics were described using mean and standard deviation in case of continuous data, and numbers and percentages in case of categorical data. To test differences in characteristics between AB+ and AB− patients, statistical testing between dichotomous data was performed using Fisher's exact test; in case of multiple categories, χ 2 test was used, and in case of continuous data independent samples t-test was used.
To describe the relation between preoperative AB+ or AB− and postoperative infections (dichotomous), logistic regression was used. To describe the relation between the two groups (AB+ or AB−) and length of stay, a Kaplan-Meier curve was used. A log-rank test was used to determine statistical differences in length of stay between the groups. To correct for confounders and to calculate differences in length of stay between the two groups, a Cox proportional hazard analysis (Cox PH) was performed. In case of multivariable logistic regression and Cox PH regression, baseline characteristics were tested for confounding (change of regression coefficient >10%) and effect modification (with the use of interaction terms). Possible confounders were added to the model, and with the use of stepwise backward selection, variables were removed until all were with P < 0.1. Since some variables were included in other variables (e.g. age, gender, creatinine in EuroSCORE), or can be intermediate factors (nitrituria), separate analyses were performed.
A P-value less than 0.05 was considered statistically significant. Statistical analysis was performed using IBM SPSS Statistics for Windows, Version 21.0.
RESULTS
After exclusions, 1002 of all 4954 screened patients (20%) who underwent surgery in 2011-2013 were found eligible ( Fig. 1 ) based on the presence of nitrite and/or leucocytes in the urine. Only 39/1002 patients (3.9%) with leucocyturia were treated with antibiotics (AB+) preoperatively. Table 1 shows characteristics of all included patients. AB+ patients were older (P = 0.06) and had a significantly higher EuroSCORE (P = 0.03). As expected, AB+ patients more often had nitrituria or higher leucocyte counts in urine, compared with AB− patients (both P < 0.001).
Types of infections and statistical comparisons are presented in Table 2 . Eighty-two patients out of 1002 (8.2%) experienced a postoperative infectious complication, 2 patients in the AB+ group (5.1%) and 80 in the AB− group (8.3%). Preoperative antibiotic treatment in case of leucocyturia seems to decrease the odds ratio (OR) of postoperative infection, although not statistically significant [OR 0.56, 95% confidence interval (CI) 0.14-2.52, P = 0.48].
There are significant baseline differences between AB+ and AB− patients in EuroSCORE and nitrituria. Since EuroSCORE is also known to be a predictor of postoperative complications, this could be an important confounding variable. The OR for postoperative infection in case of preoperative treatment with antibiotics corrected for EuroSCORE, by using multivariate logistic regression, was slightly lower (OR 0.53, 95% CI 0.12-2.24, P = 0.39) compared with univariate analysis, but still not statistically significant. Nitrituria can be a confounder. Adding nitrituria to our logistic regression resulted in a lower OR of 0.27. This too was not statistically significant (95% CI 0.06-1.29, P = 0.10). Since nitrituria can also be an intermediate variable, we chose to use the results of the logistic regression, only corrected for EuroSCORE.
As presented in Table 2 , the median length of postoperative stay does not show much difference between the AB+ and the AB− group (0.19 day difference in median postoperative stay, P = 0.54). It should be kept in mind that not only patients who died were censored, but also patients who were transferred to another hospital.
A Cox PH regression analysis was performed to calculate the difference in postoperative length of stay for both treatment groups, corrected for confounders. When corrected for age, creatinine, EuroSCORE and isolated coronary artery bypass grafting (CABG), the hazard ratio (HR) is 1.08 (95% CI 0.65-1.81), P = 0.76. Since
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age, creatinine and isolated CABG are also part of EuroSCORE, this analysis is also performed with only correction for EuroSCORE, the result does not show a statistically significant difference [HR 1.05 (95% CI 0.63-1.75, P = 0.85)] in length of stay between the two groups. In univariate analysis presence of nitrituria was not associated with differences in postoperative length of stay for both groups. Therefore, we did not include nitrituria in the Cox PH regression. Table 3 shows the urine culture results of the AB+ patients (n = 39). These results were only known postoperatively. As given in Table 3 , 33 of 39 AB+ patients (84.6%) had a preoperative positive urine culture, and treatment seemed justified. In this group of 33 AB+ patients with a preoperative positive urine culture two postoperative infections occurred (urinary tract infection and vascular prosthesis infection).These infections were caused by different bacteria, not sensitive to nitrofurantoin, which was given to treat the preoperative E. coli infection.
Analysis of culture results
Six of 39 AB+ patients (15.4%) did not have significant growth in their urine cultures, or their cultures seemed contaminated. These patients therefore did receive antibiotic treatment unnecessarily.
Twenty-four of 39 AB+ patients (61.5%) also had their urine routinely tested postoperatively. Five of these 24 postoperative urine cultures remained positive, and at least 2 of these had bacterial species different from their preoperative ones.
Eighty of 963 patients in the AB− group (despite nitrituria or leucocyturia) had a postoperative infection (8.3%), of whom 26 had a preoperative positive urine culture (32.5%). To study whether preoperative bacteriuria leads to postoperative infections by haematogenous spread of bacteria, we focussed on patients with a preoperative positive urine culture (26 out of 80 patients) ( Table 4) .
Postoperative infection other than urinary tract infection in AB− patients was never caused by the same micro-organism as found in their urine preoperatively. Table 4 also shows that urine of patients with a postoperative infection and a preoperative positive urine culture was, in routine postoperative tests, often found to be clean (in 20 of 26 cases a growth of <1000 m.o/ml).
Of 10 patients with postoperatively registered urinary tract infection, 6 initially had clean urine samples postoperatively. In about half of these, the same bacterial species were found as in preoperative urine cultures. In the other half, other micro-organisms later caused urinary tract infection. The only patient with postoperative reported urosepsis (E. coli) (given in Table 2 ) had a preoperative urine culture with less than 100 m.o./ml. This indicated that none of the AB− patients with E. coli in urine suffered from urosepsis postoperatively.
Among the 80 patients with postoperative infections, 6 patients died, of whom 2 had positive urine cultures preoperatively (Table 4 ). Both of these 2 patients had their urine tested postoperatively, and these tests were negative. Later in the postoperative period they both suffered from pneumonia, caused by different micro-organisms from the ones found in their urine. It is not known if pneumonia was the cause of death, because postmortem examination was not performed.
DISCUSSION
This study has revealed practice variations in preoperative treatment of asymptomatic bacteriuria, within the context of Urine is routinely cultured at the intensive care unit, some patients only stay at the post anesthesia care unit, and are therefore not routinely cultured. d No growth ≤100/ml, no significant growth ≤1000/ml or 1000-100 000/ml if considered contaminated by the microbiological laboratory. 
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guidelines, that leave room for discussion. Our aim was to collect evidence to support future decisions about treatment of asymptomatic bacteriuria, by examining current treatment strategies in relation to postoperative outcome. The low percentage of only 3.9% of patients for whom antibiotic treatment was started after positive preoperative urinalysis (the AB+ group) is in accordance with results described in other studies of routine preoperative urinalysis in other patient populations. Systematic review of the literature for the NICE guideline showed a weighted mean of 3.5% of change in clinical management after routine preoperative urinalysis [5] . The reasons for practice variation remained unclear.
Practice variation can lead to over-treatment and under-treatment. With regard to over-treatment: of the low number of only 39 AB+ patients, no less than 6 patients received treatment while their preoperative urine cultures retrospectively were negative, and therefore their treatment has been unnecessary (Table 3) .
How about the 963 AB− patients with nitrite and/or leucocytes in their urine before operation? Was under-treatment the case here? First of all, the perioperative antibiotic prophylaxis often led to clean urine postoperatively (Table 4) . Postoperatively, these patients had a slightly higher number of infections than the AB+ patients (5.1 vs 8.3%, Table 2 ). However, this difference in infection rate could be explained by the absence of respiratory tract infections in the small treatment group. None of the patients had a postoperative infection due to the haematogenous spread of bacteria from the urinary tract (Table 4) . This is in accordance with results of other studies. For example, Soltanzadeh and Ebadi [13] found no significant difference in the number of infections, when comparing groups of cardiac surgery patients with preoperatively untreated bacteriuria and patients without bacteriuria. Also, Cordero et al. [11] reported that in hip arthroplasty patients no arthroplasty infections were found with the same bacteria as those found in urine cultures of non-treated patients.
All this could lead to the conclusion that in this large cohort of AB− patients, the infectious complications that occurred did not seem to be associated with preoperative bacteriuria. Undertreatment seems not to have been the case. We can safely conclude that, in our clinical set-up, it seems safe to refrain from antibiotics preoperatively in patients with leucocyturia and/or nitrituria who are asymptomatic and have a low CRP level prior to cardiothoracic surgery.
Thus, neither the hypothesis of haematogenous spread of bacteria during surgery (if treatment is withheld), nor the hypothesis that the risk of infections with pathogenic bacteria is increased by preoperative treatment with antibiotics, is supported by our data. 
Limitations
There are a number of limitations to this study. First of all, this was a retrospective cohort study and not a randomized controlled trial (RCT). A comparison of AB+ and AB− patients has its drawbacks, since results could easily be biased by many confounders, and due to the small AB+ group, extensive statistical analysis was not possible. Results might not be generalizable, as the study was performed in a setting using local protocols. Also, patients were selected on the basis of leucocyturia and nitrituria instead of urine culture results. If we had included patients only with asymptomatic bacteriuria based on culture results, the results would have given a more precise relation between asymptomatic bacteriuria and postoperative outcome. Our choice to include patients with leucocyturia and/or nitrituria instead of bacteriuria was based on the circumstance that not all culture results were conveniently available. The advantages were that this approach reflects daily practice, and we were able to detect over-treatment. Furthermore, our cut-off points for inclusion and exclusion are a subject for discussion. We included all patients with leucocyturia, including 301 patients with only a trace of leucocytes in urine. It is considered normal to have up to 15 leucocytes per high-power field in urine. Since treatment was started also in patients with a trace of leucocytes, the inclusion of these patients reflects daily practice. A second cut-off point is a CRP level higher than 10 mg/l. We considered these patients as symptomatic, and therefore excluded them. Therefore, our results are not generalizable to patients with higher CRP levels.
Another limitation is that some variables of interest are not systematically registered, and have therefore not been included in our study. An example is the patients' urological history.
Current daily practice for preoperative antibiotic therapy in case of asymptomatic bacteriuria is based on expert opinion, rather than on evidence. The reason for this is the limited amount of available evidence. Our findings have important implications for clinicians and policy-makers.
In our cohort of 963 patients with nitrituria and/or leucocyturia, who had not been treated preoperatively (AB−), it seems safe to refrain from preoperative antibiotic treatment in patients with leucocyturia and/or nitrituria who are asymptomatic and have a low CRP level prior to cardiothoracic surgery. This is based on the non-significant statistical differences between the AB+ and AB− patients, but even more on the culture results of our large AB− group, which did not show an association between preoperative urine culture results and postoperative infectious complications other than urinary tract infections.
CONCLUSION
The risk of haematogenous spread of bacteria seems to be nonexistent in this large cohort of non-treated patients, under our local clinical practice. Based on this currently best available evidence, it seems therefore safe to not treat patients with asymptomatic bacteriuria prior to cardiothoracic surgery. This could also imply not to perform routine preoperative urine testing. If stronger level of evidence is required, a large multicentre RCT would be preferable.
